Dr Anurag Agrawal, director of the CSIR-Institute of Genomics & Integrative Biology (IGIB), believes air pollution, along with ethnicity, physical activity, nutrition, upbringing are the major factors behind this.
The Shanti Swarup Bhatnagar awardee has now undertaken a major study to pinpoint the relative contribution of these factors in his capacity as a senior fellow of the Wellcome Trust - DBT India Alliance.
Also Read
FVC is the total amount of air exhaled as hard and as fast as possible after maximum inhalation, which, he said, was a major indicator of a person's susceptibility to cardiovascular diseases, even more than cholesterol.
"It means an average Indian being measured by American standards would fall into restrictive low lung function capacity. People in this category have been shown to die much faster of diabetes, heart attacks and stroke," Agrawal told PTI.
The Wellcome Trust/DBT India Alliance is an initiative funded equally by the Wellcome Trust, UK and Department of Biotechnology, India.
A recent study, by the department of pulmonary medicine at the Vallabhbhai Patel Chest Institute, found that the lung capacity of children in Delhi was 10 per cent lower than those in the US or those of Caucasian origin.
However, in this case, the researchers had developed India-specific norms in arriving at the conclusion, to minimise possible errors arising out of direct comparison with American standards.
But Agrawal disagrees. He said doing so, just to make 90 per cent of Indians feel that they have normal lung capacity, would be a "disservice".
"Only if people are told they are at higher risk will they focus on nutrition, lifestyle. Of course, air pollution is one part of the story. The study I have undertaken will bring out whether we have genuinely healthy small lungs or diseased lungs," he said.
A report released by the Centre for Science and Environment (CSE) yesterday says every third child in Delhi has impaired lungs.
CSIR-IGIB is an institute of Council of Scientific and Industrial Research (CSIR), engaged in research of national importance in the areas of genomics, molecular medicine, bioinformatics, proteomics and environmental biotechnology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)